Newsfeeds

Google News

Asahi Kasei Pharma Applies for Approval of Famvir for Additional Indication - MarketWatch (press release)

Asahi Kasei Pharma Applies for Approval of Famvir for Additional Indication
MarketWatch (press release)
Tokyo, Feb 07, 2012 (JCN via COMTEX) -- Asahi Kasei Pharma Corp. recently filed an application for approval of the antiviral agent Famvir, which was developed in Japan jointly with Maruho Co. Ltd, for the additional indication of herpes simplex.

and more »

Travel curbs slapped on pharma company owners - The Express Tribune

The Express Tribune

Travel curbs slapped on pharma company owners
The Express Tribune
By Rana Tanveer The Lahore High Court on Monday was told that the names of the owners of the pharmaceutical company Efroze Chemicals Ltd, involved in the faulty medicine debacle, had been placed on the Exit Control List (ECL).

and more »

Akela Pharma Secures US $2.3 Million Financing - TechFinance

Akela Pharma Secures US $2.3 Million Financing
TechFinance
Akela Pharma, Inc. (TSX: AKL) and it's wholly owned subsidiary PharmaForm, has completed a US 2.31 million private placement of Senior Secured Notes and Senior Secured Convertible Notes. The private placement consists of US $1205000 8% Senior Secured ...
Akela Pharma, Inc. and PharmaForm Announce Completion of A USD $2.3 Million ...DigitalJournal.com (press release)

all 4 news articles »

Cadence Pharma To Recall One Lot Of Ofirmev Injection - Wall Street Journal

Cadence Pharma To Recall One Lot Of Ofirmev Injection
Wall Street Journal
Cadence Pharmaceuticals Inc. (CADX) said it is voluntarily recalling one lot of its Ofirmev injection after an unidentified particle was found in one of the lot's vials during routine stability testing. The biopharmaceutical company said the lot was ...
Cadence Pharma Recalls Single Lot Of Ofirmev Injection - Quick FactsNASDAQ

all 12 news articles »

Amylin Pharma Q4 Loss Widens - Quick Facts - NASDAQ

Amylin Pharma Q4 Loss Widens - Quick Facts
NASDAQ
(RTTNews.com) - Amylin Pharmaceuticals Inc. (AMLN) reported that its fourth-quarter GAAP net loss widened to $461.5 million or $3.15 per share, from $19.2 million, or $0.13 per share in the year ago quarter. Net costs to reacquire economic interest in ...
Amylin Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call TranscriptSeeking Alpha
Amylin Pharma (AMLN) Reports Q4 GAAP Loss of $3.15/ShareStreetInsider.com (subscription)
Inside Wall Street: Is Amylin a buyout target?MSN Money

all 19 news articles »

Big Pharma should learn from Hogwarts - Financial Times

Big Pharma should learn from Hogwarts
Financial Times
Publishers dream of discovering a new mega-seller; pharmaceuticals companies yearn for more blockbuster drugs. But when these gift horses come trotting by, how many companies think beyond the proverbial advice not to attempt a full dental examination?

and more »

Anacor Pharma drops as study enrollment is stopped - CBS News

Anacor Pharma drops as study enrollment is stopped
CBS News
(AP) NEW YORK — Shares of Anacor Pharmaceuticals Inc. dropped more than 8 percent Monday after the company said its partner GlaxoSmithKline PLC stopped enrolling patients in studies of an anti-infection drug. THE SPARK: Anacor said the halt resulted ...
Anacor Pharma Says GSK Voluntarily Paused Enrollment Of Ongoing GSK '052 TrialsNASDAQ

all 28 news articles »

Does Anavex Life Sciences (AVXL) Have the Next Big Thing Big Pharma Wants? - SmallCap Network

Does Anavex Life Sciences (AVXL) Have the Next Big Thing Big Pharma Wants?
SmallCap Network
By Bryan Murphy If there's one thing big pharma has telegraphed in the last few weeks, it's a renewed willingness to spend big bucks to refill dying pipelines. As an example, Gilead Sciences, Inc. (NASDAQ:GILD) bought out Pharmasset, Inc. (NASDAQ:VRUS) ...
4 Biotech Stocks To Buy, 1 To Avoid For NowSeeking Alpha

all 11 news articles »

ACADIA Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor ... - MarketWatch (press release)

Proactive Investors USA & Canada

ACADIA Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor ...
MarketWatch (press release)
SAN DIEGO, Feb 06, 2012 (BUSINESS WIRE) -- ACADIA Pharmaceuticals Inc. /quotes/zigman/85163/quotes/nls/acad ACAD +3.39% , a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments ...
ACADIA PHARMACEUTICALS INC. : ACADIA Pharmaceuticals to Present at the 14th ...4-traders (press release)

all 69 news articles »

Former Pharma Exec Charged in NY Death Fights Jail Call Recording - Pharmaceutical Processing

Former Pharma Exec Charged in NY Death Fights Jail Call Recording
Pharmaceutical Processing
By JENNIFER PELTZ,AP NEW YORK (AP) — A pharmaceuticals multimillionaire charged with murdering her autistic 8-year-old son at a hotel has lost a bid to stop jail officials from recording her phone calls and turning them over to prosecutors.

and more »

Follow/Join us on:

Facebook

Twitter

RSS

Sponsored Links

Latest News

Industry News

More information